Fuda Cancer Hospital
Radiotherapy for prostate cancer in China typically costs from $14,500 to $31,500. The final price depends on the chosen technology, hospital classification, and case complexity. In the United States, similar treatments cost around $35,000 on average. Patients can find savings of approximately 34% in China. Packages usually include the radiation sessions, initial consultations, and treatment planning.
Bookimed Expert Insight: China offers high-value oncology care at JCI-accredited facilities like Fuda Cancer Hospital. This clinic specializes in treating advanced-stage cancer and uses unique minimally invasive alternatives. For radiotherapy, choosing a Class-III general hospital like Jinshazhou Hospital provides access to European-standard protocols. Their massive volume of 680,000 annual patients ensures high clinical expertise. International departments there provide multilingual support, making complex navigation much easier for foreign patients.
| China | Turkey | Austria | |
| Radiotherapy for prostate cancer | from $14,500 | from $4,000 | from $14,000 |
Day 1
Day 2
Day 3
Week 1
Week 2 - Week 7
Week 8
Week 9 - Week 12
Week 13
Please note that individual experiences may vary, and the above timeline is a general guide. Always consult your doctor for personalized advice.
Dr. Liu Shi Xin is the Vice Chairman of the Radiation Oncology Branch of the Chinese Medical Association. He serves as the Discipline Leader of the Oncology Center at Xiamen Humanity Hospital. Dr. Liu specializes in precision radiotherapy for thoracic and abdominal cancers. He is a recipient of the State Council Special Government Allowance for his medical contributions.
Dr. Niu Lizhi is the President and chief surgeon at Fuda Cancer Hospital in Guangzhou. He has performed nearly 10,000 cryosurgeries and 500 NanoKnife procedures. Dr. Niu specializes in minimally invasive oncology for lung, pancreatic, and liver cancers. He treats patients ranging from early childhood through age 94.
This procedure uses radiation to target and destroy cancer cells in the prostate gland.